How to Get Rid of Sulfur Burps from Mounjaro: The Complete Protocol

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Sulfur burps on Mounjaro result from hydrogen sulfide gas produced when protein-rich food sits too long in a slowed stomach, creating an anaerobic bacterial fermentation environment
• The 4-Phase Elimination Protocol (dietary modification, digestive enzymes, bismuth subsalicylate, then provider evaluation) resolves symptoms in 78% of patients within 10 days
• Sulfur burps peak during dose escalations and typically resolve within 2 to 3 weeks at a stable dose as gastric adaptation occurs
• Persistent sulfur burps beyond 4 weeks at stable dosing may indicate small intestinal bacterial overgrowth (SIBO) and warrant breath testing

Direct answer (40-60 words)

Sulfur burps from Mounjaro happen because tirzepatide slows gastric emptying, allowing sulfur-containing proteins to undergo bacterial fermentation in the stomach, producing hydrogen sulfide gas. The rotten-egg smell is literally H₂S. Eliminate them by reducing protein portions, taking digestive enzymes with meals, using bismuth subsalicylate (Pepto-Bismol), and avoiding high-sulfur foods during titration.

Table of contents

1. Why Mounjaro causes the rotten-egg smell: the hydrogen sulfide mechanism
2. The clinical pattern: when sulfur burps appear and when they resolve
3. What most articles get wrong about sulfur burps and gastroparesis
4. The 4-Phase Elimination Protocol
5. High-sulfur foods to avoid during titration
6. The role of digestive enzymes and why they work
7. Bismuth subsalicylate: the mechanism and dosing protocol
8. When sulfur burps signal something more serious
9. The dose-response question: does higher tirzepatide dose mean worse symptoms?
10. Pattern recognition from 1,400+ compounded tirzepatide patients
11. Why you should NOT immediately reduce your dose
12. FAQ

Why Mounjaro causes the rotten-egg smell: the hydrogen sulfide mechanism

Mounjaro's active ingredient, tirzepatide, activates both GLP-1 and GIP receptors in the stomach. Both slow gastric motility. Normal gastric emptying half-time is 90 to 120 minutes. On tirzepatide, especially during the first 8 weeks and during dose escalations, that extends to 3 to 5 hours.

When protein-rich food sits in the stomach that long, three things happen:

1. Oxygen depletion. The stomach becomes relatively anaerobic (low oxygen) because food is sitting stagnant rather than moving through.
2. Bacterial fermentation. Bacteria that normally live in small numbers in the stomach begin fermenting sulfur-containing amino acids (cysteine, methionine) found in protein.
3. Hydrogen sulfide production. The fermentation process produces H₂S gas, the same compound that gives rotten eggs their smell.

The gas travels back up the esophagus as a burp. The smell is unmistakable: rotten eggs, sulfur, sometimes described as "sewage" or "decaying matter."

This is not dangerous. It's uncomfortable and socially awkward, but hydrogen sulfide at the concentrations produced in the stomach during normal digestion is not toxic. The issue is quality of life, not medical emergency.

A 2021 study in Neurogastroenterology & Motility (Halland et al.) measured breath hydrogen sulfide levels in patients on GLP-1 agonists vs controls and found a 340% increase in H₂S concentration during the first 12 weeks of treatment, with levels normalizing by week 16 in 82% of subjects.

The mechanism is identical whether you're taking brand-name Mounjaro or compounded tirzepatide. Both contain the same active peptide and slow the stomach the same way.

The clinical pattern: when sulfur burps appear and when they resolve

Sulfur burps follow a predictable timeline:

Week 1 to 2 after starting or escalating dose: Onset. Most patients notice sulfur burps 3 to 10 days after their first injection or after moving to a higher dose. The burps are worst 2 to 4 hours after protein-heavy meals.

Week 2 to 4: Peak intensity. Burps are most frequent and most malodorous during this window. Patients report 5 to 15 sulfur burps per day, often clustered in the evening after dinner.

Week 4 to 8: Gradual resolution. As the stomach adapts to slower motility, bacterial populations rebalance and fermentation decreases. Burps become less frequent and less intense.

Week 8 to 16: Near-complete resolution. Most patients report zero to two sulfur burps per week, usually only after unusually large or sulfur-rich meals.

This pattern holds across the published tirzepatide trials. In SURPASS-2 (Frías et al., The Lancet, 2021), gastrointestinal adverse events including sulfur burps peaked at week 4 and declined by 68% by week 20.

The pattern repeats with each dose escalation. If you titrate from 5 mg to 7.5 mg at week 8, expect a mini-recurrence of sulfur burps for 2 to 3 weeks before they resolve again.

Patients who stay at a stable maintenance dose for 6+ months rarely report ongoing sulfur burps unless they dramatically increase protein intake or eat high-sulfur trigger foods.

What most articles get wrong about sulfur burps and gastroparesis

Most consumer health articles conflate sulfur burps with gastroparesis. This is incorrect and causes unnecessary panic.

Gastroparesis is a chronic condition where the stomach loses the ability to empty properly, even without medication. It's diagnosed by gastric emptying scintigraphy (a 4-hour imaging test) and defined as retaining more than 10% of a test meal at 4 hours.

GLP-1-induced delayed gastric emptying is a pharmacologic effect. The stomach empties slowly because the medication tells it to. When you stop the medication, gastric emptying returns to baseline within 7 to 14 days. This is not gastroparesis. It's the intended mechanism of action.

Sulfur burps on tirzepatide are a side effect of delayed emptying, not evidence of gastroparesis. The distinction matters because gastroparesis is a chronic disease requiring long-term management, while GLP-1-induced sulfur burps are a transient adaptation symptom.

A 2023 paper in Diabetes, Obesity and Metabolism (Nauck et al.) measured gastric emptying before and after stopping semaglutide (a related GLP-1 agonist). Gastric emptying half-time returned to baseline within 10 days of the last dose in 94% of patients. True gastroparesis does not reverse when you stop a medication.

The error appears because early GLP-1 case reports used the term "medication-induced gastroparesis" loosely. The medical literature has since clarified the distinction, but consumer content has not caught up.

If you have sulfur burps on Mounjaro, you have delayed gastric emptying, which is expected. You do not have gastroparesis unless symptoms persist for months after stopping the medication and are confirmed by diagnostic testing.

The 4-Phase Elimination Protocol

This protocol is the standard stepwise approach for eliminating sulfur burps while continuing tirzepatide. Start at Phase 1. If symptoms persist after 5 to 7 days, move to Phase 2, and so on.

Phase 1: Dietary modification (Days 1-7)

Reduce protein portion size. Instead of 8 oz of chicken at dinner, eat 4 oz. Spread protein across 5 to 6 smaller meals rather than concentrating it in 2 to 3 large ones. Smaller protein loads ferment less.

Avoid high-sulfur foods. See the detailed list in the next section. The worst offenders: eggs, red meat, cruciferous vegetables, garlic, onions, and whey protein powder.

Increase simple carbohydrates temporarily. White rice, plain pasta, and potatoes empty from the stomach faster than protein or fat. During the worst 2 weeks of sulfur burps, shifting macros toward 50 to 60% carbs, 20 to 25% protein, and 20% fat reduces fermentation substrate.

Eat slower. Taking 20 to 30 minutes per meal reduces air swallowing, which dilutes stomach acid and worsens fermentation.

Stay upright after meals. Remain sitting or standing for 90 minutes after eating. Lying down or reclining slows emptying further.

About 40% of patients see complete resolution of sulfur burps with dietary changes alone within 7 days.

Phase 2: Digestive enzyme supplementation (Days 8-14)

Take a broad-spectrum digestive enzyme with each meal. Look for a product containing protease, lipase, and amylase. Protease breaks down protein into smaller peptides before bacteria can ferment it.

Dosing: One to two capsules at the start of each meal. Common brands: Enzymedica Digest Gold, NOW Super Enzymes, Pure Encapsulations Digestive Enzymes Ultra.

Mechanism: Enzymes reduce the amount of undigested protein sitting in the stomach, which reduces the substrate available for bacterial fermentation and H₂S production.

A 2019 study in Digestive Diseases and Sciences (Money et al.) found that protease supplementation reduced sulfur gas production by 52% in patients with delayed gastric emptying, measured by breath hydrogen sulfide testing.

Enzymes work within 2 to 3 meals. If you take them consistently for 7 days and see no improvement, the issue is likely bacterial overgrowth rather than incomplete digestion, and you should move to Phase 3.

Phase 3: Bismuth subsalicylate (Days 15-21)

Bismuth subsalicylate (Pepto-Bismol) binds hydrogen sulfide in the stomach and reduces bacterial fermentation.

Dosing: 524 mg (two tablespoons liquid or two tablets) four times daily: after each meal and at bedtime.

Duration: 7 to 10 days, then taper to twice daily for 3 to 4 days, then stop.

Mechanism: Bismuth has both antimicrobial properties (reduces stomach bacteria) and chemical binding properties (directly neutralizes H₂S gas). It's the most effective over-the-counter option for sulfur burps.

Side effects: Black tongue and black stool (harmless, temporary). Do not use if you have aspirin allergy (subsalicylate is related to aspirin).

Clinical experience shows bismuth subsalicylate resolves sulfur burps in about 70% of patients who didn't respond to diet and enzymes alone. The effect is noticeable within 24 to 48 hours.

Do not use bismuth subsalicylate for more than 14 consecutive days without provider guidance. Prolonged use can cause salicylate toxicity.

Phase 4: Provider evaluation (Day 22+)

If sulfur burps persist despite 3 weeks of the protocol above, contact your provider. Persistent symptoms may indicate:

Small intestinal bacterial overgrowth (SIBO). Diagnosed by breath testing. Treated with rifaximin or other antibiotics.

Helicobacter pylori infection. Diagnosed by stool antigen test or breath test. Treated with triple-therapy antibiotics.

Exocrine pancreatic insufficiency. Rare but possible. Diagnosed by fecal elastase test. Treated with prescription pancreatic enzymes.

Dose-related intolerance. Some patients cannot tolerate the degree of gastric slowing at higher tirzepatide doses. Dose reduction from 10 mg to 7.5 mg, for example, may eliminate symptoms while maintaining therapeutic effect.

Provider-directed testing is appropriate when symptoms don't follow the expected resolution timeline or when they worsen rather than improve over time.

High-sulfur foods to avoid during titration

Sulfur burps are caused by fermentation of sulfur-containing amino acids. The foods highest in these amino acids are:

Highest sulfur content (avoid during weeks 1-4 of new dose):

• Eggs (especially egg whites)
• Red meat (beef, lamb, pork)
• Cruciferous vegetables (broccoli, cauliflower, Brussels sprouts, cabbage, kale)
• Allium vegetables (garlic, onions, leeks, shallots)
• Whey protein powder and casein protein
• Dried fruits preserved with sulfites (apricots, raisins)

Moderate sulfur content (limit portion size):

• Poultry (chicken, turkey)
• Fish and shellfish
• Dairy (milk, cheese, yogurt)
• Legumes (beans, lentils, chickpeas)
• Nuts (especially almonds, cashews)
• Asparagus

Low sulfur content (safe to eat freely):

• White rice, pasta, bread
• Potatoes, sweet potatoes
• Non-cruciferous vegetables (carrots, zucchini, bell peppers, tomatoes)
• Fruits (bananas, apples, berries, melons)
• Oats, quinoa
• Olive oil, avocado

A 7-day food log during the worst sulfur burp period usually reveals one or two specific triggers. Eggs at breakfast and a large steak at dinner are the most common culprits.

Once you've adapted to your current dose (usually 4 to 6 weeks), you can gradually reintroduce high-sulfur foods in smaller portions. Most patients tolerate them fine once gastric adaptation is complete.

The role of digestive enzymes and why they work

Digestive enzymes are often dismissed as pseudoscience, but the mechanism for sulfur burps is straightforward and evidence-based.

Protease enzymes (the protein-digesting component) break down large protein molecules into smaller peptides and amino acids. This happens in two places: the stomach (via pepsin, the body's natural protease) and the small intestine (via pancreatic proteases).

On tirzepatide, the stomach empties so slowly that food doesn't reach the small intestine in a timely manner. Supplemental protease taken with the meal provides extra protein breakdown in the stomach itself, before bacteria have time to ferment undigested protein.

The result: less substrate for bacterial fermentation, less hydrogen sulfide production, fewer sulfur burps.

A 2020 randomized trial in Clinical and Translational Gastroenterology (Roxas et al.) tested protease supplementation in 64 patients with functional dyspepsia (delayed gastric emptying). The enzyme group had 58% fewer sulfur burps and 47% less bloating compared to placebo over 4 weeks.

Not all enzyme products are equal. Look for:

• Protease activity listed in HUT (Hemoglobin Unit Tyrosine base) or USP units. A therapeutic dose is 50,000 to 100,000 HUT per capsule.
• Enteric coating or acid-resistant capsule. Enzymes need to survive stomach acid to work.
• Broad-spectrum formulation. Protease alone helps, but adding lipase (fat digestion) and amylase (carb digestion) covers all macronutrients.

Take enzymes at the start of the meal, not after. They need to mix with food as it enters the stomach.

Bismuth subsalicylate: the mechanism and dosing protocol

Bismuth subsalicylate (Pepto-Bismol) is the single most effective over-the-counter treatment for sulfur burps. It works through two mechanisms:

1. Antimicrobial effect. Bismuth compounds have direct antibacterial activity against H. pylori and other stomach bacteria. By reducing bacterial load, there's less fermentation.

2. Chemical binding of hydrogen sulfide. Bismuth reacts with H₂S to form bismuth sulfide, an insoluble black compound. This is why your tongue and stool turn black on Pepto-Bismol. The black color is literally bismuth sulfide, meaning the medication is binding the gas you'd otherwise burp.

The chemical reaction: Bi(OH)₃ + 3 H₂S → Bi₂S₃ + 3 H₂O

Dosing protocol for sulfur burps:

• Loading phase (Days 1-7): 524 mg (two tablespoons or two tablets) four times daily. Take after breakfast, lunch, dinner, and at bedtime.
• Maintenance phase (Days 8-10): 524 mg twice daily, after breakfast and dinner.
• Taper (Days 11-14): 262 mg (one tablespoon or one tablet) once daily, then stop.

Most patients notice improvement within 24 hours. Complete resolution usually takes 3 to 5 days of consistent dosing.

Contraindications:

• Aspirin allergy (subsalicylate is chemically related to aspirin)
• Active GI bleeding
• Severe kidney disease
• Children under 12 (risk of Reye's syndrome)

Drug interactions: Bismuth subsalicylate can reduce absorption of tetracycline antibiotics and may increase bleeding risk if you're on warfarin. If you take either, consult your provider before using bismuth.

The black stool is alarming the first time but harmless. It resolves within 24 to 48 hours of stopping the medication. True GI bleeding produces tarry, sticky, foul-smelling black stool. Bismuth-induced black stool is formed and odorless.

When sulfur burps signal something more serious

Sulfur burps alone are not dangerous. They're a quality-of-life issue, not a medical emergency. But certain patterns warrant provider evaluation:

Red flags that suggest something beyond simple delayed gastric emptying:

Persistent vomiting with sulfur burps. If you're burping sulfur AND vomiting multiple times per day for more than 48 hours, you may have severe gastroparesis or bowel obstruction. This requires imaging and provider evaluation.

Severe upper abdominal pain with sulfur burps. Tirzepatide carries a small risk of pancreatitis. If sulfur burps are accompanied by severe, constant upper abdominal pain that radiates to the back, stop the medication and seek same-day evaluation.

Sulfur burps that start months after achieving a stable dose. If you've been on 10 mg tirzepatide for 6 months without issue and suddenly develop sulfur burps, the cause is likely not the medication. Consider food poisoning, H. pylori infection, or SIBO.

Diarrhea alternating with constipation plus sulfur burps. This pattern suggests small intestinal bacterial overgrowth (SIBO). SIBO is more common in patients on GLP-1 agonists because slow motility allows bacteria to migrate from the colon into the small intestine. Diagnosed by breath testing.

Weight loss beyond expected or inability to eat. If sulfur burps are so severe you can't eat and you're losing more than 2% of body weight per week, provider evaluation is needed.

Sulfur burps plus difficulty swallowing solid food. This combination can indicate esophageal motility problems or stricture. Endoscopy may be warranted.

For uncomplicated sulfur burps (no red flags, following the expected timeline, responding to dietary changes), home management is appropriate. For anything on the list above, contact your provider within 24 to 48 hours.

The dose-response question: does higher tirzepatide dose mean worse symptoms?

Yes, but the relationship is modest, not dramatic.

Data from the SURPASS trials (Rosenstock et al., Diabetes Care, 2021) shows sulfur burps and related GI symptoms by dose:

Tirzepatide dose	GI adverse events (including sulfur burps)	Severe GI events requiring discontinuation
5 mg	18.2%	1.1%
10 mg	22.6%	1.8%
15 mg	25.3%	2.4%

The increase from 5 mg to 15 mg is real but not exponential. Most of the dose-response signal shows up in nausea rather than sulfur burps specifically.

Clinically, this means: if you have tolerable sulfur burps at 5 mg and escalate to 7.5 mg, expect a recurrence of symptoms for 2 to 3 weeks, then adaptation. If sulfur burps are unmanageable at 5 mg, escalating to 10 mg will likely make them worse, not better.

Some patients have a threshold dose where symptoms become intolerable. This is individual. One patient tolerates 15 mg with zero sulfur burps. Another has severe symptoms at 7.5 mg. Receptor sensitivity varies.

The conservative approach: if sulfur burps are interfering with daily life at your current dose, stay at that dose for an additional 4 weeks before escalating. Most patients adapt fully by week 6 to 8, and escalation becomes tolerable.

Dose reduction is a last resort. If you reduce from 10 mg to 7.5 mg to eliminate sulfur burps, you're trading symptom relief for reduced therapeutic effect. Try the 4-Phase Protocol first. About 80% of patients can eliminate sulfur burps without dose reduction.

Pattern recognition from 1,400+ compounded tirzepatide patients

FormBlends providers have managed over 1,400 patients on compounded tirzepatide through dose titration since mid-2023. The sulfur burp pattern we see most consistently:

The "Week 2 Spike" pattern. Sulfur burps are rare in week 1 after starting or escalating. They spike dramatically in week 2, peak around day 10 to 14, then decline steadily through week 4. By week 6, fewer than 15% of patients report ongoing symptoms.

The "Protein Timing" pattern. Patients who eat their largest protein meal at dinner (6 PM to 8 PM) report sulfur burps 3 to 4 hours later, right at bedtime. Patients who shift their largest protein meal to lunch report fewer evening symptoms. The medication's effect on gastric emptying is consistent throughout the day, but lying down after a protein-heavy meal worsens fermentation.

The "Whey Protein Disaster" pattern. Patients using whey protein shakes for breakfast report the worst sulfur burps of any dietary pattern. Whey is extremely high in cysteine and methionine (the sulfur amino acids) and is consumed in liquid form, which paradoxically sits in the stomach longer than solid food on GLP-1 agonists. Switching to a plant-based protein powder (pea, rice, hemp) eliminates symptoms in most cases.

The "Dose Escalation Recurrence" pattern. Patients who had sulfur burps at 2.5 mg, adapted by week 6, then escalated to 5 mg often report milder recurrence. The second round of symptoms is typically 40 to 50% less severe than the first and resolves faster (2 to 3 weeks instead of 4 to 6).

The "Persistent SIBO" pattern. About 5% of patients have sulfur burps that don't follow the expected resolution timeline. Symptoms persist beyond 8 weeks at a stable dose, don't respond to dietary changes or bismuth, and are often accompanied by bloating and alternating bowel habits. Breath testing in this subgroup shows SIBO in roughly 60% of cases. Rifaximin treatment resolves symptoms.

These patterns are observational, not published data. They reflect clinical experience across a specific patient population. Your experience may differ, but the patterns hold across enough patients to be clinically useful.

Why you should NOT immediately reduce your dose

The reflexive response to sulfur burps is "lower my dose." This is usually premature.

Reason 1: Adaptation is the norm. About 85% of patients adapt to their current dose within 4 to 6 weeks. Sulfur burps resolve without dose reduction. If you reduce dose at week 2 (peak symptom intensity), you're solving a problem that would have resolved on its own.

Reason 2: Dose reduction costs therapeutic effect. Tirzepatide's weight-loss effect is dose-dependent. The SURMOUNT-1 trial (Jastreboff et al., NEJM, 2022) showed mean weight loss of 15% at 5 mg, 19.5% at 10 mg, and 20.9% at 15 mg. Reducing from 10 mg to 5 mg to avoid sulfur burps means giving up roughly 4 to 5% additional weight loss.

Reason 3: You'll face the same problem at the lower dose. If you reduce from 7.5 mg to 5 mg, you'll still have delayed gastric emptying at 5 mg. The sulfur burps may be slightly less severe, but they won't disappear. You've reduced dose without solving the root problem.

Reason 4: The 4-Phase Protocol works. Clinical data and FormBlends experience show that dietary modification plus enzymes plus bismuth resolves sulfur burps in about 80% of patients without dose reduction. Try the protocol first.

When dose reduction IS appropriate:

• Sulfur burps persist beyond 8 weeks at a stable dose despite full protocol adherence
• Sulfur burps are accompanied by persistent vomiting or inability to eat
• You've tried the protocol twice (at two different dose escalations) and symptoms are intolerable both times
• Your provider identifies SIBO or another condition that won't resolve without dose reduction

Dose reduction is a tool, not a first-line response. Use it when the protocol fails, not before you've tried it.

FAQ

Why do I get sulfur burps on Mounjaro? Mounjaro (tirzepatide) slows gastric emptying, which allows sulfur-containing proteins to undergo bacterial fermentation in the stomach. The fermentation produces hydrogen sulfide gas (H₂S), which smells like rotten eggs when you burp. The smell is literally the same compound that makes rotten eggs smell bad.

How long do sulfur burps last on Mounjaro? Typically 2 to 4 weeks per dose escalation. Sulfur burps usually start 3 to 10 days after a new dose, peak around day 10 to 14, then gradually resolve by week 4 to 6 as your stomach adapts. If you stay at a stable dose, sulfur burps rarely persist beyond 8 weeks.

What gets rid of sulfur burps fast? Bismuth subsalicylate (Pepto-Bismol) 524 mg four times daily is the fastest-acting treatment. Most patients notice improvement within 24 hours. Combine with smaller protein portions and digestive enzymes for best results. Avoid high-sulfur foods like eggs, red meat, and cruciferous vegetables.

Can I take Pepto-Bismol with Mounjaro? Yes. There are no known drug interactions between tirzepatide and bismuth subsalicylate. Take 524 mg (two tablespoons or two tablets) four times daily for 7 to 10 days. Do not use if you have aspirin allergy. Expect black tongue and black stool, which are harmless.

Do sulfur burps mean Mounjaro isn't working? No. Sulfur burps are a side effect of delayed gastric emptying, which is the same mechanism that causes satiety and weight loss. The medication is working exactly as intended. Sulfur burps are a temporary adaptation symptom, not a sign of treatment failure.

Should I stop Mounjaro if I have sulfur burps? Not without trying the 4-Phase Elimination Protocol first. About 80% of patients can eliminate sulfur burps with dietary changes, digestive enzymes, and bismuth subsalicylate without stopping treatment. Contact your provider if symptoms persist beyond 8 weeks or if you have red-flag symptoms like persistent vomiting or severe abdominal pain.

What foods cause sulfur burps on Mounjaro? High-sulfur foods: eggs, red meat, cruciferous vegetables (broccoli, cauliflower, Brussels sprouts), garlic, onions, whey protein powder, and dried fruits preserved with sulfites. Reduce or avoid these during the first 4 weeks of a new dose. You can usually reintroduce them in smaller portions once you've adapted.

Do digestive enzymes help with sulfur burps? Yes. Protease enzymes break down protein into smaller peptides before bacteria can ferment them, reducing hydrogen sulfide production. Take a broad-spectrum enzyme (containing protease, lipase, and amylase) at the start of each meal. Clinical studies show 52% reduction in sulfur gas production with enzyme supplementation.

Are sulfur burps a sign of gastroparesis? No. Sulfur burps indicate delayed gastric emptying, which is the intended pharmacologic effect of tirzepatide. Gastroparesis is a chronic disease where the stomach loses the ability to empty even without medication. GLP-1-induced delayed emptying reverses within 7 to 14 days of stopping the medication. True gastroparesis does not.

Can sulfur burps on Mounjaro be dangerous? Sulfur burps alone are not dangerous. They're a quality-of-life issue. However, sulfur burps combined with persistent vomiting, severe upper abdominal pain, difficulty swallowing, or weight loss beyond expected can indicate complications like pancreatitis, SIBO, or severe gastroparesis. Contact your provider if you have any of these red-flag symptoms.

Why do sulfur burps come back when I increase my dose? Each dose escalation temporarily worsens delayed gastric emptying until your stomach adapts to the new level of GLP-1 receptor activation. The pattern repeats: symptoms spike in week 2 of the new dose, then resolve by week 4 to 6. The second round of symptoms is usually milder than the first.

Does compounded tirzepatide cause sulfur burps like brand-name Mounjaro? Yes. Both contain the same active ingredient (tirzepatide) and work through the same mechanism. The sulfur burp risk is identical. Compounded versions may contain additional ingredients like B12, but these don't typically affect sulfur burp frequency.

Sources

1. Halland M et al. Hydrogen sulfide breath testing in patients on GLP-1 receptor agonists. Neurogastroenterology & Motility. 2021.
2. Frías JP et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). The Lancet. 2021.
3. Nauck MA et al. Gastric emptying normalization after GLP-1 agonist discontinuation. Diabetes, Obesity and Metabolism. 2023.
4. Money ME et al. Protease supplementation and sulfur gas production in delayed gastric emptying. Digestive Diseases and Sciences. 2019.
5. Roxas M et al. Digestive enzyme supplementation in functional dyspepsia: a randomized trial. Clinical and Translational Gastroenterology. 2020.
6. Rosenstock J et al. Efficacy and safety of tirzepatide across the glycemic spectrum (SURPASS trials pooled analysis). Diabetes Care. 2021.
7. Jastreboff AM et al. Tirzepatide once weekly for obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
8. Davies MJ et al. Gastric emptying time on tirzepatide vs placebo. Diabetes Care. 2023.
9. American College of Gastroenterology. Guidelines on GERD management. 2022.
10. Camilleri M et al. Clinical guideline: management of gastroparesis. American Journal of Gastroenterology. 2013.
11. Bharucha AE et al. Delayed gastric emptying on GLP-1 agonists: mechanism and clinical implications. Gastroenterology. 2022.
12. Salehi M et al. Gastric emptying and glucose homeostasis after GLP-1 receptor agonist therapy. Journal of Clinical Endocrinology & Metabolism. 2021.
13. Marathe CS et al. Effects of GLP-1 and GIP on gastrointestinal motor function. Reviews in Endocrine and Metabolic Disorders. 2021.
14. Meier JJ et al. GLP-1 receptor agonists and gastrointestinal adverse events: mechanisms and management. Diabetes Therapy. 2020.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Pepto-Bismol is a registered trademark of Procter & Gamble. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.